ACCELERON PHARMA INC Insider Trading for June 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for June 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 5.08 | 1,600 | 8,128 | 22,296 | |
| Jun 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 0.48 | 4,000 | 1,920 | 8,000 | |
| Jun 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 31.07 | 400 | 12,428 | 12,700 | 13.1 K to 12.7 K (-3.05 %) |
| Jun 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 31.57 | 1,000 | 31,570 | 13,100 | 14.1 K to 13.1 K (-7.09 %) |
| Jun 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 31.57 | 5,600 | 176,792 | 32,004 | 37.6 K to 32 K (-14.89 %) |
| Jun 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 5.08 | 1,600 | 8,128 | 37,604 | 36 K to 37.6 K (+4.44 %) |
| Jun 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 0.48 | 4,000 | 1,920 | 36,004 | 32 K to 36 K (+12.50 %) |
| Jun 18 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 3.88 | 7,701 | 29,880 | 28,539 | |
| Jun 18 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 3.88 | 7,701 | 29,880 | 22,701 | 15 K to 22.7 K (+51.34 %) |
| Jun 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.88 | 5,500 | 32,340 | 9,961 | |
| Jun 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 31.13 | 5,500 | 171,215 | 15,000 | 20.5 K to 15 K (-26.83 %) |
| Jun 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.88 | 5,500 | 32,340 | 20,500 | 15 K to 20.5 K (+36.67 %) |
| Jun 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 24,500 | |
| Jun 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 31.11 | 2,000 | 62,220 | 57,656 | 59.7 K to 57.7 K (-3.35 %) |
| Jun 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 2,000 | 7,760 | 59,656 | 57.7 K to 59.7 K (+3.47 %) |
| Jun 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 60,751 | |
| Jun 10 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 35,000 | 30 K to 35 K (+16.67 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 1,500 | 5,820 | 65,751 | |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 67,251 | |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.96 | 200 | 6,592 | 30,000 | 30.2 K to 30 K (-0.66 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.37 | 1,300 | 42,081 | 30,200 | 31.5 K to 30.2 K (-4.13 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 31,500 | 30 K to 31.5 K (+5.00 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.97 | 100 | 3,297 | 30,000 | 30.1 K to 30 K (-0.33 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 32.49 | 4,900 | 159,201 | 30,100 | 35 K to 30.1 K (-14.00 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 35,000 | 30 K to 35 K (+16.67 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 3.88 | 19,000 | 73,720 | 43,500 | |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.94 | 600 | 19,764 | 17,584 | 18.2 K to 17.6 K (-3.30 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 32.50 | 18,400 | 598,000 | 18,184 | 36.6 K to 18.2 K (-50.30 %) |
| Jun 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 3.88 | 19,000 | 73,720 | 36,584 | 17.6 K to 36.6 K (+108.05 %) |